Olympia Compounding Pharmacy is categorized under in Orlando, FL and active since 2009.
Olympia Compounding Pharmacy was established in 2009, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Marco Loleit, Owner at the company’s single location by writing to 6700 Conroy Windermere Road # 140, Orlando, Florida FL 32835 or by phoning (407) 673-2222. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Olympia Compounding Pharmacy |
| Contact Person: | Marco Loleit, Owner |
| Address: | 6700 Conroy Windermere Road # 140, Orlando, Florida 32835 |
| Phone Number: | (407) 673-2222 |
| Website Address: | olympiapharmacy.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Olympia Compounding Pharmacy was started in 2009 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Marco Loleit, Owner for inquiries that concern Olympia Compounding Pharmacy by calling the company number (407) 673-2222, as your correspondence is most welcome. Additionally, the physical location of the single location of Olympia Compounding Pharmacy can be found at the coordinates 28.49364,-81.472207 as well as the street address 6700 Conroy Windermere Road # 140 in Orlando, Florida 32835.
For its online presence, you may visit Olympia Compounding Pharmacy’s website at olympiapharmacy.com and engage with its social media outlets through on Twitter and on Facebook.